series-c-plus
Stage
1
Investors
About
Natera, Inc develops and provides noninvasive cell-free DNA testing for applications in oncology, women’s health, organ health, and rare disease detection to inform personalized healthcare decisions.
Explore Natera, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.